Medtronic (NYSE:MDT) announced today that it launched its Medtronic Extended Infusion set for seven-day wear with insulin delivery.
The Medtronic Extended Infusion Set represents the first and only infusion set labeled for wearing of up to seven days. The infusion set for delivering insulin from a pump to the body typically requires changing every two to three days. It is available exclusively for customers using MiniMed 600 and 700 series pumps. Medtronic developed it in partnership with Convatec Infusion Care.
Medtronic designed its infusion set with advanced materials for reducing insulin preservative loss and maintaining insulin flow. This helps provide stability, doubling the wear time of a typical infusion set. It leverages proprietary technology, including a new tubing connector for improving insulin’s physical and chemical stability. The connector also enhances the reliability of infusion site performance and reduces the risk of infusion set occlusion.
The system also features an adhesive patch with a layer that helps extend wear time and provide comfort and durability. Medtronic said its Extended reservoir represents the only infusion set reservoir tested and cleared for this duration, too.
“When patients first begin using a pump, doctors and other healthcare providers reinforce the need to change their infusion set every two to three days to limit the risk of infection and other safety concerns. For many people, this means scheduling life around infusion set changes, which may not be at the most convenient times ― turning around as you are headed out the door when you suddenly remember to change your infusion set or adding a few minutes to a tired child’s bedtime routine with an infusion set change,” said Dr. Robert Vigersky, CMO, Medtronic Diabetes. “With the Medtronic Extended infusion set, these life interruptions are reduced with an innovation that doubles the wear.”
About the benefits of the infusion set
Studies demonstrated a decrease in the number of changes for the infusion set by 50%. Users also observed lower infusion set failures associated with high glucose levels. Participants stated that the new infusion set offered more comfortability compared to their previous sets. They presented happiness with the longer wear time as it helped reduce the overall burden of insulin pump therapy.
Additionally, Medtronic said its Extended set could provide insulin cost savings of up to 25%. This is due to a reduced number of set and reservoir changes that result in unrecoverable insulin. It also attributed this to up to 50% in plastic waste reduction.
“Our goal is to make life easier for individuals living with diabetes and the Medtronic Extended infusion set helps us deliver on this with prolonged and more comfortable wear – something customers have been requesting for many years,” said Que Dallara, EVP & president, Medtronic Diabetes. “We couldn’t be more pleased to launch this innovation during Diabetes Awareness Month when we take the time to reflect on what more we can do to alleviate the burden for those living with this chronic condition.
“We’re pleased to deliver a groundbreaking innovation that will make a real difference in the overall pump experience given the overwhelming and well-documented benefits of this therapeutic option.”